Jashin J Wu Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

3/2024	Executive Summary: From the Medical Board of the National Psoriasis Foundation: Perioperative management of immunomodulatory agents in patients with psoriasis and psoriatic arthritis.
12/2023	Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States.
12/2023	Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies.
12/2023	Real-world dose escalation of biologics for moderate-to-severe psoriasis in the United States.
12/2023	Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis.
11/2023	Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment - a Nationwide Cohort Study.
8/2023	The use of ultrasound to detect enthesitis as a potential guide for intervention in patients with psoriasis at risk of psoriatic arthritis: a systematic review.
6/2023	Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey.
2/2023	New Treatments for Psoriasis: An Update on a Therapeutic Frontier.
1/2023	Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jashin J Wu Research Topics

Disease

167	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 06/2008
19	Atopic Dermatitis (Atopic Eczema) 12/2023 - 03/2019
18	Psoriatic Arthritis 03/2024 - 01/2009
15	Infections 03/2022 - 01/2004
9	COVID-19 12/2022 - 01/2020
9	Rheumatoid Arthritis 06/2020 - 01/2009
8	Neoplasms (Cancer) 06/2023 - 01/2004
7	Virus Diseases (Viral Diseases) 12/2022 - 09/2003
7	Myocardial Infarction 08/2014 - 11/2012
5	Hypertension (High Blood Pressure) 01/2023 - 02/2014
5	Pain (Aches) 12/2021 - 09/2003
4	Hidradenitis Suppurativa 02/2024 - 01/2017
4	Skin Diseases (Skin Disease) 08/2022 - 03/2008
4	Inflammation (Inflammations) 01/2020 - 10/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 08/2017 - 01/2014
3	Acne Vulgaris 12/2024 - 09/2020
3	Pruritus (Itching) 08/2022 - 08/2017
3	Dermatitis 08/2022 - 10/2002
3	Skin Neoplasms (Skin Cancer) 06/2022 - 10/2002
3	Body Weight (Weight, Body) 05/2022 - 10/2011
3	Mycoses (Diseases, Fungus) 10/2020 - 01/2004
3	Latent Tuberculosis 06/2020 - 09/2015
3	Herpes Zoster 06/2020 - 09/2003
2	Drug-Related Side Effects and Adverse Reactions 12/2024 - 02/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2024 - 08/2013
2	Obesity 01/2023 - 10/2021
2	Lung Diseases (Lung Disease) 01/2023 - 04/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2023 - 07/2017
2	Lentigo (Lentiginosis) 06/2022 - 01/2019
2	Pemphigus (Pemphigus Vulgaris) 05/2022 - 01/2015
2	Neutropenia 02/2021 - 10/2015
2	Diarrhea 02/2021 - 03/2016
2	Headache (Headaches) 02/2021 - 03/2016
2	Chronic Disease (Chronic Diseases) 09/2020 - 06/2020
2	Ankylosing Spondylitis 06/2020 - 08/2013

Drug/Important Bio-Agent (IBA)

26	Adalimumab (Humira)FDA Link 02/2024 - 05/2011
20	Tumor Necrosis Factor InhibitorsIBA 12/2023 - 11/2012
19	Etanercept (Enbrel)FDA Link 05/2022 - 12/2007
18	apremilastIBA 12/2023 - 01/2015
17	Ustekinumab (CNTO 1275)FDA Link 02/2024 - 08/2012
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2020 - 01/2009
13	secukinumabIBA 02/2024 - 01/2018
13	Methotrexate (Mexate)FDA LinkGeneric 02/2021 - 01/2012
12	Interleukin-23 (Interleukin 23)IBA 12/2023 - 06/2008
12	Interleukin-17 (Interleukin 17)IBA 12/2022 - 02/2018
11	ixekizumabIBA 03/2022 - 01/2012
10	brodalumabIBA 02/2021 - 10/2015
9	Infliximab (Remicade)FDA Link 02/2024 - 10/2011
9	CytokinesIBA 08/2022 - 01/2005
8	Monoclonal AntibodiesIBA 05/2022 - 01/2012
8	guselkumabIBA 03/2022 - 01/2018
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2015
6	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 01/2023 - 08/2019
6	calcipotriene (calcipotriol)FDA LinkGeneric 01/2023 - 08/2019
6	dupilumabIBA 02/2022 - 01/2020
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2021 - 03/2016
6	Antiviral Agents (Antivirals)IBA 04/2017 - 09/2003
5	tazarotene (Tazorac)FDA Link 11/2022 - 06/2020
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2024 - 01/2004
4	Interleukin-12 (IL 12)IBA 07/2021 - 06/2008
4	InterleukinsIBA 07/2021 - 08/2018
4	Acitretin FDA Link 02/2021 - 12/2007
4	Biosimilar PharmaceuticalsIBA 08/2020 - 01/2017
3	RetinoidsIBA 12/2024 - 09/2020
3	Immunomodulating AgentsIBA 03/2024 - 10/2016
3	risankizumabIBA 12/2023 - 01/2020
3	halobetasol (ulobetasol)FDA LinkGeneric 11/2022 - 06/2020
3	Vitamin D FDA LinkGeneric 08/2022 - 01/2018
3	tildrakizumabIBA 03/2022 - 01/2019
3	omega-Chloroacetophenone (Mace)IBA 10/2021 - 08/2016
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 08/2021 - 03/2016
3	tofacitinibIBA 02/2021 - 11/2016
3	Leflunomide (Arava)FDA LinkGeneric 06/2020 - 01/2016
2	Interleukin InhibitorsIBA 12/2023 - 10/2020
2	lebrikizumabIBA 06/2023 - 03/2022
2	Ficusin (Psoralen)IBA 06/2023 - 06/2022
2	RoflumilastIBA 02/2023 - 01/2023
2	tapinarofIBA 02/2023 - 10/2020
2	insulin receptor-related receptor (IRR)IBA 01/2023 - 12/2022
2	COVID-19 VaccinesIBA 01/2023 - 01/2023
2	AntibodiesIBA 12/2022 - 03/2019
2	AerosolsIBA 11/2022 - 12/2021
2	SteroidsIBA 08/2022 - 07/2018
2	Coal Tar (Estar)IBA 08/2022 - 05/2018
2	Calcineurin InhibitorsIBA 08/2022 - 10/2020
2	Immunoglobulin A (IgA)IBA 05/2022 - 08/2021
2	Janus Kinase InhibitorsIBA 01/2022 - 03/2018
2	FumaratesIBA 02/2021 - 06/2020
2	Interleukin-17 ReceptorsIBA 02/2021 - 01/2018
2	ruxolitinibIBA 11/2020 - 10/2020
2	crisaboroleIBA 10/2020 - 03/2019
2	Prostaglandins AIBA 06/2020 - 03/2016

Therapy/Procedure

82	Therapeutics 12/2023 - 09/2003
24	Phototherapy (Light Therapy) 06/2023 - 10/2011
15	Biological Therapy 12/2023 - 01/2016
4	Contraindications 02/2022 - 08/2019
3	Duration of Therapy 10/2022 - 03/2016
2	Immunotherapy 03/2022 - 04/2004
2	Aftercare (After-Treatment) 08/2021 - 07/2017
2	Excimer Lasers 11/2020 - 09/2019